The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels

Background. We used a random sample (n = 2, 495) from the population-based Prevention of Renal and Vascular End-stage Disease (PREVEND) study population to examine the association of the metabolic syndrome (Met S) with plasminogen activator inhibitor type 1 (PAI-1) and tissue plasminogen activator (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Coffey, Christopher S., Asselbergs, Folkert W., Hebert, Patricia R., Hillege, Hans L., Li, Qing, Moore, Jason H., van Gilst, Wiek H.
Format: Artigo
Idioma:Inglês
Publicat: SAGE-Hindawi Access to Research 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3087975/
https://ncbi.nlm.nih.gov/pubmed/21559217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/541467
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars